{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:04:24Z","timestamp":1740114264228,"version":"3.37.3"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100028612","name":"Kaiser Permanente Division of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","award":["K23 MH126078"],"award-info":[{"award-number":["K23 MH126078"]}],"id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.psychres.2024.116273","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T15:08:10Z","timestamp":1731856090000},"page":"116273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of intravenous ketamine with change in depressive symptoms in a large integrated health care system"],"prefix":"10.1016","volume":"343","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-544X","authenticated-orcid":false,"given":"Li","family":"Kevin\u2024J\uff0e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4930-1061","authenticated-orcid":false,"given":"Slama","family":"Natalie\u2024E\uff0e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2950-5069","authenticated-orcid":false,"given":"Chen","family":"Ingrid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0008-9052","authenticated-orcid":false,"given":"Lee","family":"Catherine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ridout","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamilton","family":"Steven\u2024P\uff0e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iturralde","family":"Esti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2024.116273_bib0001","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2023.01.005","article-title":"Antidepressant and anti-suicidal effects of ketamine in treatment-resistant depression associated with psychiatric and personality comorbidities: a double-blind randomized trial","volume":"325","author":"Ahmed","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.116273_bib0002","doi-asserted-by":"crossref","first-page":"17m11634","DOI":"10.4088\/JCP.17m11634","article-title":"Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression","volume":"79","author":"Albott","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116273_bib0003","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2024.116273_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2018.04.016","article-title":"Treatment-resistant depression and suicidality","volume":"235","author":"Bergfeld","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.116273_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JCP.0000000000001149","article-title":"Metabolic syndrome rather than body mass index is associated with treatment response to ketamine infusions","volume":"40","author":"Dale","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.116273_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115133","article-title":"Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder","volume":"323","author":"Danayan","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2024.116273_bib0007","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116273_bib0008","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/JCP.0000000000001209","article-title":"Body mass index as a moderator of treatment response to ketamine for major depressive disorder","volume":"40","author":"Freeman","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.116273_bib0009","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.4088\/JCP.14m09049","article-title":"Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine","volume":"75","author":"Ionescu","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116273_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.2836","article-title":"Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression","volume":"37","author":"Jesus-Nunes","year":"2022","journal-title":"Human Psychopharmacol.: Clin. Experim."},{"key":"10.1016\/j.psychres.2024.116273_bib0011","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2337\/dc12-0722","article-title":"Elevated rates of diabetes in Pacific Islanders and Asian subgroups: the Diabetes Study of Northern California (DISTANCE)","volume":"36","author":"Karter","year":"2013","journal-title":"Diabetes Care."},{"key":"10.1016\/j.psychres.2024.116273_bib0012","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jad.2021.12.097","article-title":"A retrospective analysis of ketamine intravenous therapy for depression in real-world care settings","volume":"301","author":"McInnes","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.116273_bib0013","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2024.116273_bib0014","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s11524-006-9094-x","article-title":"The development of a standardized neighborhood deprivation index","volume":"83","author":"Messer","year":"2006","journal-title":"J. Urban Health"},{"key":"10.1016\/j.psychres.2024.116273_bib0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: a Two-Site Randomized Controlled Trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116273_bib0016","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0269881113478283","article-title":"Serial infusions of low-dose ketamine for major depression","volume":"27","author":"Rasmussen","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.116273_bib0017","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116273_bib0018","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jad.2020.07.089","article-title":"Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: a retrospective chart review","volume":"276","author":"Sakurai","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.116273_bib0019","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jad.2024.01.165","article-title":"Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study","volume":"350","author":"Vestring","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2024.116273_bib0020","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the yale psychiatric hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2024.116273_bib0021","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124005584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124005584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T13:35:36Z","timestamp":1734010536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124005584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":21,"alternative-id":["S0165178124005584"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116273","relation":{},"ISSN":["0165-1781"],"issn-type":[{"type":"print","value":"0165-1781"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of intravenous ketamine with change in depressive symptoms in a large integrated health care system","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.116273","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116273"}}